Agilent (A) Gets a Buy Rating from Morgan Stanley

By Austin Angelo

Morgan Stanley analyst Steve Beuchaw maintained a Buy rating on Agilent (AResearch Report) today and set a price target of $89. The company’s shares opened today at $66.25.

According to TipRanks.com, Beuchaw is a 4-star analyst with an average return of 8.4% and a 56.8% success rate. Beuchaw covers the Healthcare sector, focusing on stocks such as Myriad Genetics, NanoString Tech, and Thermo Fisher.

Currently, the analyst consensus on Agilent is a Moderate Buy with an average price target of $83.

See today’s analyst top recommended stocks >>

The company has a one-year high of $75 and a one-year low of $60.42. Currently, Agilent has an average volume of 2.42M.

Based on the recent corporate insider activity of 71 insiders, corporate insider sentiment is negative on the stock. Most recently, in September 2018, Heidi Fields, a Director at A sold 5,482 shares for a total of $371,296.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates through the following segments: Life Sciences & applied markets; Diagnostics & Genomics; and Agilent CrossLab Business.